Deciphering hygromycin B biosynthetic pathway and D-optimal design for production optimization
Muath Suliman1, Amr S Bishr2, Khaled M Aboshanab3,4
1Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, P.O. Box 61413, 9088, Abha, Saudi Arabia.
World Journal of Microbiology & Biotechnology
|April 27, 2025
Summary
This study optimized Hygromycin B (HYG-B) production by optimizing Streptomyces hygroscopicus culture conditions. Statistical optimization using D-optimal design significantly increased HYG-B yield, paving the way for industrial applications.
Area of Science:
- Microbiology
- Biotechnology
- Biochemistry
Background:
- Hygromycin B (HYG-B) is a broad-spectrum aminoglycoside antibiotic produced by Streptomyces hygroscopicus.
- Limited research exists on HYG-B biosynthesis and production optimization.
- Understanding and enhancing HYG-B production is crucial for its therapeutic applications.
Purpose of the Study:
- To optimize environmental conditions for enhanced Hygromycin B production.
- To elucidate the biosynthetic pathway of Hygromycin B.
- To evaluate the efficacy of statistical optimization methods for antibiotic production.
Main Methods:
- One-factor-at-a-time (OFAT) approach to study media composition and incubation time.
- Response surface methodology using a D-optimal design (DOD) for optimizing pH, temperature, and agitation.
- Analysis of gene/protein identification for proposed biosynthetic pathway elucidation.
Main Results:
- OFAT optimization identified optimal media (CM6) and incubation time (7 days), yielding a sevenfold increase in HYG-B.
- DOD quadratic model optimized initial pH (6.4), temperature (28°C), and agitation (295 rpm).
- The optimized conditions resulted in a 13-fold increase in HYG-B production (371.5 µg/mL) compared to unoptimized conditions.
Conclusions:
- D-optimal design is an effective tool for optimizing Hygromycin B production.
- Optimized fermentation conditions significantly enhance HYG-B yield from Streptomyces hygroscopicus.
- Further scale-up in bioreactors is recommended for industrial production of Hygromycin B.
Keywords:
S. hygroscopicus NRRL ISP-55782-Dexoystreptamine-aminoglycosideD-optimal designHygromycin BResponse surface method (RSM)More Related Videos
Related Concept Videos
Lipid Catabolism
1.4K
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
1.4K
Biosynthesis in Bacteria
1.0K
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
1.0K
Bioreactor Controls-III
67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
Methods of Medium Optimization
70
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
70
Upstream Processing
97
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
97
Production of Pharmaceuticals
94
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
94


